Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free

Did Korro Bio Beat Earnings?

Korro Bio (KRRO) reported Q2 '26 revenue of $0, down 100.0% year-over-year.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Korro Bio’s job postings, web traffic, and employee business outlook. See the full KRRO stock analysis or the earnings calendar for upcoming reports.

Korro Bio Quarterly Financial Trends (USD)

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue—2.3M2.6M1.5M1.1M1.3M——
Gross margin—100.0%100.0%100.0%100.0%49.8%——
Operating margin—-1,014.5%-981.2%-1,863.2%-1,764.9%-1,229.3%——
Net income-21M-21M-23M-26M-18M-50M-20M-19M
Net margin—-933.5%-917.1%-1,765.1%-1,657.0%-3,873.2%——
EPS————————

Korro Bio Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Korro Bio’s quarterly revenue moved from $0 to $0.

When Is Korro Bio’s Next Earnings Date?

Korro Bio reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the KRRO earnings calendar.

Frequently Asked Questions: Korro Bio Earnings

Korro Bio's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Korro Bio reported Q2 '26 revenue of $0, down 100.0% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the KRRO AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.